Vivos Therapeutics (VVOS) Free Cash Flow Growth (3y) (2023 - 2026)
Powered by 
Analysis
Vivos Therapeutics (VVOS) Free Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | -6.67% |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | 19.58% |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | -8.16% |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | 27.01% |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | -12.77% |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | -5.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.10% |
| Mar 31, 2026 | -16.85% |
| Dec 31, 2025 | -36.70% |
| Sep 30, 2025 | 11.58% |
| Jun 30, 2025 | 6.04% |
| Mar 31, 2025 | 14.25% |
| Dec 31, 2024 | 12.04% |
| Sep 30, 2024 | 0.47% |
| Jun 30, 2024 | 14.39% |
| Mar 31, 2024 | 13.79% |
| Dec 31, 2023 | 7.96% |
| Sep 30, 2023 | -62.66% |
| Jun 30, 2023 | -47.99% |
| Mar 31, 2023 | -104.44% |